The European biological sample handling market is forecast to grow at a CAGR of around 8.4% during the forecast period. Europe is expected to share significantly in the global biological sample handling market owing to the well-developed healthcare sector, and significant research in the field of geniomics and protecomics in its economies such as UK, Germany, Italy, Spain and many more. A major factor which is augmenting the market is high incidences of diseases in the region. In order to provide better healthcare facilities, companies as well as research institutes are focusing on R&D activities. Cancer is one of the most prevalent diseases in the region.
As per the World Health Organization, Europe accounts for 23.5% of the global cases of cancer in 2018, which is 4.23 million. Due to which various organizations are focusing particularly on cancer including King’s Health Partners Cancer Biobank, Manchester Cancer Research Centre Biobank, Wales Cancer Bank, Applied Research on Cancer Centre (ARC-NET) and so on.
Presence of various biobanks in the country including CEH Fish Tissue Archive, Frozen Ark Project, King’s Health Partners Cancer Biobank, Wales Cancer Bank and so on is a major factor for having significant share. Investment collaboration is also augmenting the market in the country such as investment of $50 million by GSK in the country. Germany is expected to be second-largest market in
EuroBioBank is a notable organization which manages a network of biobanks in Europe. The organization provides human DNA, cell, and tissue samples to the scientific community for research on rare diseases. The organizations offer catalog lists with the samples available throughout the EuroBioBank network. A researcher can browse sample-level information using a filtering function of disease name, code or material type. As of February 2016, more than 4,410 samples were available in their catalog.
Research Methodology
The market study of the European Biological Sample Handling market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for biological sample handling companies, storage companies, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. European Biological Sample Handling Market by Storage Type
5.1.1. Cold Storage
5.1.2. Room Temperature Storage
5.2. European Biological Sample Handlings Market by Application
5.2.1. Drug Discovery
5.2.2. Forensic Investigation
5.2.3. DNA Extraction
5.2.4. Proteomics and Genomics Studies
5.2.5. Others
5.3. European Biological Sample Handlings Market by Ownership
5.3.1. Commercial
5.3.2. Academic/Research
6. Regional Analysis
6.1. UK
6.2. Germany
6.3. Italy
6.4. France
6.5. Spain
6.6. Rest of Europe
7. Company Profiles
7.1. Alliance Pharma PLC
7.2. Abbott Laboratories
7.3. Becton, Dickinson And Co.
7.4. Brooks Automation, Inc.
7.5. Fisher BioServices
7.6. Indivumed GmbH
7.7. ReproCELL Europe Ltd.
7.8. Sigma-Aldrich Co. LLC.
7.9. Technidata
1. EUROPEAN BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH AND ANALYSIS BY STORAGE TYPE, 2018-2025 ($ MILLION)
2. EUROPEAN BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
3. EUROPEAN BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH AND ANALYSIS BY OWNERSHIP, 2018-2025 ($ MILLION)
4. EUROPEAN BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
1. EUROPEAN BIOLOGICAL SAMPLE HANDLING MARKET SHARE BY STORAGE TYPE, 2018 VS 2025 (%)
2. EUROPEAN BIOLOGICAL SAMPLE HANDLING MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
3. EUROPEAN BIOLOGICAL SAMPLE HANDLING MARKET SHARE BY OWNERSHIP, 2018 VS 2025 (%)
4. EUROPEAN BIOLOGICAL SAMPLE HANDLING MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
5. UK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2025 ($ MILLION)
6. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2025 ($ MILLION)
7. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2025 ($ MILLION)
8. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2025 ($ MILLION)
9. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2025 ($ MILLION)
10. REST OF EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2025 ($ MILLION)